As promised, here’s the replay.
Strongly suggest you listen and share. Especially if you’re confused over the HR2058 Bill and Cole-Bishop Amendment.
*Ashley Davis, partner at West Front Strategies analyzes the HR2058 Bill & Cole/Bishop amendment, what they mean and what the industry and community need to do.
*Also Scott Eley joins us to discuss the industry led litigation against the overreaching onerous FDA deeming regulations.